Analysts expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to post $35.30 billion in sales for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Walgreens Boots Alliance’s earnings. The highest sales estimate is $36.13 billion and the lowest is $34.87 billion. Walgreens Boots Alliance posted sales of $34.53 billion during the same quarter last year, which suggests a positive year over year growth rate of 2.2%. The company is scheduled to report its next earnings results on Tuesday, April 7th.
On average, analysts expect that Walgreens Boots Alliance will report full year sales of $139.90 billion for the current financial year, with estimates ranging from $137.29 billion to $144.37 billion. For the next fiscal year, analysts anticipate that the business will post sales of $144.11 billion, with estimates ranging from $140.96 billion to $153.24 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, January 8th. The pharmacy operator reported $1.37 earnings per share for the quarter, missing analysts’ consensus estimates of $1.40 by ($0.03). The company had revenue of $34.34 billion for the quarter, compared to analysts’ expectations of $34.45 billion. Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.46 earnings per share.
Shares of NASDAQ WBA opened at $52.04 on Friday. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.31. The stock has a market capitalization of $47.32 billion, a P/E ratio of 12.79, a price-to-earnings-growth ratio of 1.36 and a beta of 0.90. Walgreens Boots Alliance has a 1-year low of $49.03 and a 1-year high of $74.94. The business has a fifty day moving average price of $57.06 and a 200 day moving average price of $55.61.
In related news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $63.16, for a total transaction of $14,801,861.80. Following the transaction, the chief accounting officer now directly owns 13,844 shares of the company’s stock, valued at approximately $874,387.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 16.91% of the company’s stock.
A number of large investors have recently made changes to their positions in WBA. Victory Capital Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 13.8% in the second quarter. Victory Capital Management Inc. now owns 76,881 shares of the pharmacy operator’s stock valued at $4,203,000 after purchasing an additional 9,305 shares during the period. Centaurus Financial Inc. increased its holdings in shares of Walgreens Boots Alliance by 329.9% in the second quarter. Centaurus Financial Inc. now owns 2,214 shares of the pharmacy operator’s stock valued at $121,000 after purchasing an additional 1,699 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of Walgreens Boots Alliance by 27.4% in the second quarter. Price T Rowe Associates Inc. MD now owns 1,920,291 shares of the pharmacy operator’s stock valued at $104,982,000 after purchasing an additional 412,903 shares during the period. Nuveen Asset Management LLC increased its holdings in shares of Walgreens Boots Alliance by 216.5% in the second quarter. Nuveen Asset Management LLC now owns 2,281,316 shares of the pharmacy operator’s stock valued at $124,720,000 after purchasing an additional 1,560,622 shares during the period. Finally, Waddell & Reed Financial Inc. acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at about $388,000. 60.48% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: What sectors are represented in the FTSE 100 index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.